Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (121-130 of 251) with videos related to

Pageof 26
Sort By:
Cancer|October 7, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 studyJohn C Araujo, Paul Mathew, Andrew J Armstrong, et al.
Cancer Research|July 19, 2005
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived productsJeri Kim, Peiying Yang, Milind Suraokar, et al.
Cells|April 14, 2019
Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic ImagingPrasanta Dutta, Travis C Salzillo, Shivanand Pudakalakatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potentialVasily J Assikis, Kim-Anh Do, Sijin Wen, et al.
The Prostate|September 21, 2007
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapiesShifeng Mao, Danai D Daliani, Xuemei Wang, et al.
BJU International|February 26, 2015
Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillancePatricia A Parker, John W Davis, David M Latini, et al.
Prostate Cancer and Prostatic Diseases|December 26, 2025
Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironmentPaul G Corn, Guoyu Yu, Yibo Fan, et al.
Cancer Research|February 24, 2025
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial TherapyYuehui Zhao, Naveen Ramesh, Ping Xu, et al.
Acta Biomaterialia|February 22, 2024
Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivoClaudia Paindelli, Vanessa Parietti, Sergio Barrios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblastsKarim Fizazi, Jun Yang, Sara Peleg, et al.
Pageof 26

Showing results (121-130 of 251) with videos related to

Sort By:
Pageof 26
Cancer|October 7, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 studyJohn C Araujo, Paul Mathew, Andrew J Armstrong, et al.
Cancer Research|July 19, 2005
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived productsJeri Kim, Peiying Yang, Milind Suraokar, et al.
Cells|April 14, 2019
Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic ImagingPrasanta Dutta, Travis C Salzillo, Shivanand Pudakalakatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potentialVasily J Assikis, Kim-Anh Do, Sijin Wen, et al.
The Prostate|September 21, 2007
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapiesShifeng Mao, Danai D Daliani, Xuemei Wang, et al.
BJU International|February 26, 2015
Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillancePatricia A Parker, John W Davis, David M Latini, et al.
Prostate Cancer and Prostatic Diseases|December 26, 2025
Spatial immune profiling of bone-metastatic castration-resistant prostate cancer reveals radium-223 immunomodulates the bone-tumor microenvironmentPaul G Corn, Guoyu Yu, Yibo Fan, et al.
Cancer Research|February 24, 2025
Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial TherapyYuehui Zhao, Naveen Ramesh, Ping Xu, et al.
Acta Biomaterialia|February 22, 2024
Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivoClaudia Paindelli, Vanessa Parietti, Sergio Barrios, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblastsKarim Fizazi, Jun Yang, Sara Peleg, et al.
Pageof 26